Immunohistochemistry in Hepatic Carcinoma

Immunohistochemical techniques is a methodology which based on antigen-antibody immunological response to its theoretical foundation. It plays an important role in basic and clinical medical research in the field of biology, especially in the diagnosis of diseases of the tumors, differential diagnosis and pathogenesis research provides a powerful tool. With the development of new technologies, hundreds of kinds of antibodies used in various areas of clinical research, the majority of these antibodies play an important supporting role in the diagnosis of difficult cases. It has important implications for the patient's prognosis and guide treatment.

Hepatic carcinoma divided into primary hepatocellular carcinoma(PHC) and metastatic hepatocellular carcinoma. Early detection, early diagnosis, early treatment is very important for PHC. There need to use immunohistochemical staining to confirm in the diagnosis of PHC, serum alpha-fetoprotein(AFP) is PHC specific markers.

Slices of hepatic carcinoma as follows:

ATP5D: 14630-T60

Immunochemical staining of human ATP5D in human hepatoma with rabbit polyclonal antibody (0.2 µg/mL, formalin-fixed paraffin embedded sections).
CTSB: 10483-T24

Immunochemical staining of human CTSB in human hepatoma with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections).
GP73: 13066-RP04

Immunochemical staining of human GP73 in human hepatoma with rabbit polyclonal antibody (0.2 µg/mL, formalin-fixed paraffin embedded sections).
RPRD1B: 14027-T44

Immunochemical staining of human GP73 in human hepatoma with rabbit polyclonal antibody (0.2 µg/mL, formalin-fixed paraffin embedded sections).